Use of Nirmatrelvir-Ritonavir, Tocilizumab and Molnupiravir for the management of patients with COVID-19

Use of Nirmatrelvir-Ritonavir, Tocilizumab and Molnupiravir for the management of patients with COVID-19
Use of Nirmatrelvir-Ritonavir, Tocilizumab and Molnupiravir for the management of patients with COVID-19

Use of Nirmatrelvir-Ritonavir, Tocilizumab, and Molnupiravir for the management of patients with COVID-19

Program

Evidence, recommendations, and considerations for the use of antivirals, monoclonal antibodies, and other interventions for the management of patients with Covid-19. 
Dr. Ariel Izcovich, PAHO/WHO Washington

Safety and pharmacovigilance considerations for the use of nirmatrelvir-ritonavir, tocilizumab and molnupiravir.
Dr. Diego Macías, PAHO/WHO Washington
Access this presentation (Available in Spanish)

 

If you missed one of our webinars, you could find it here.